Difluoromethylornithine enhanced uptake of tritiated putrescine in 9L rat brain tumors

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 1, 1997, Pages 169-174

  Redgate, Edward S ^a   Grudziak, A G ^a   Deutsch, M ^a   Boggs, S S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

9L glioma; 3H putrescine; Difluoromethylornithine (DFMO); Osmotic pumps; Radioemitters

Indexed keywords

EFLORNITHINE; PUTRESCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; DRUG UPTAKE; GLIOSARCOMA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; BRAIN NEOPLASMS; EFLORNITHINE; GLIOMA; MALE; ORNITHINE DECARBOXYLASE; PUTRESCINE; RATS; RATS, INBRED F344;

EID: 0031127323     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00243-5     Document Type: Article

References (19)

1. 3H] thymidine increases killing of rat gliosarcoma cells in vitro. Radiat. Oncol. Invest. 1:325-333; 1994.
2. 2. Boucher, Y.; Baxter, L. T.; Jain, R. K. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: Implications for therapy. Cancer Res. 50:4478-4484; 1990.
3. 3. Cserr, H. F. Relationship between cerebrospinal fluid and interstitial fluid of brain. Fluids of the brain. Fed. Proc. 33:2075-2078; 1974.
4. 4. Genedani, S.; Bernardi, M.; Botticelli, A.; Bertolini, A. Convulsive syndrome induced by the intracerebroventricular injection of α-difluoromethylornithine in rats. Acta. Pharmacol. Toxicol. 56:250-253; 1985.
5. 5. Greig, N. H. Optimizing drug delivery to brain tumors. Cancer Treat. Rev. 14:1-28; 1987.
6. 6. Jain, R. K. Delivery of molecular medicine to solid tumors. Science 271:1079-1080; 1996.
7. 7. Kroin, J. S.; Penn, R. D. Intracerebral chemotherapy: Chronic microinfusion of cisplatin. Neurosurgery 10:349-354; 1982.
8. 8. McCann, P. P.; Pegg, A. E. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol, Ther. 54:195-215; 1992.
9. 9. Redgate, E. S.; Boggs, S.; Grudziak, A.; Deutsch, M. Polyamines in brain tumor therapy. J. Neurooncology 25:167-179; 1995.
10. 3H] putrescine uptake on 9L tumor cell growth and colony forming efficiency. Int. J. Radiat. Oncol. Biol. Phys. 25:639-646; 1993.
11. 11. Rewers, A. B.; Redgate, E. S.; Deutsch, M.; Fisher, E. R.; Boggs, S. S. A new rat brain tumor: Glioma disseminated via the cerebral spinal fluid pathways. J. Neurooncology 8:213-219; 1990.
12. 12. Schmidek, H. H.; Nielsen, S. L.; Schiller, A. L.; Messer, J. Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J. Neurosurg. 34:335-340; 1971.
13. 13. Seidenfeld, J.; Levin, V. A.; Devor, W. N.; Marton, L. J. Kinetics and distribution of tritiated putrescine in the domestic cat. Eur. J. Cancer 15:1319-1327; 1979.
14. 14. Sendelbeck, S. L.; Urquhart, J. Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion. Brain Res. 328:251-258; 1985.
15. 15. Siemann, D. W.; Lord, E. M.; Keng, P. C.; Wheeler, K. T. Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation. Br. J. Cancer 44:100-108; 1981.
16. 16. Strasser, J. F.; Fung, L. K.; Eller, S.; Grossman, A.; Saltzman, W. M. Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in rabbit brain after interstitial delivery by biodegradable polymer implants. JPET 275:1647-1655; 1995.
17. 17. Tomita, T. Interstitial chemotherapy for brain tumors: Review. J. Neurooncology 10:57-74; 1991.
18. 18. Urquhart, J.; Fara, J. W.; Willis, K. L. Rate-controlled delivery systems in drug and hormone research. Annu. Rev. Pharmacol. Toxicol. 24:199-236; 1984.
19. 19. Wheeler, K. T.; Barker, M.; Wallen, C. A.; Kimler, B. F.; Henderson, S. D. Evaluation of 9L as a brain tumor model. In: Sridhar, R., ed. Methods in tumor biology: Tissue culture and animal tumor models. New York: Marcel Dekker, Inc.; 1984:259-336.